Test to improve stem cell safety

Jun 04, 2013

CSIRO scientists have developed a test to identify unsafe stem cells. It is the first safety test specifically for human induced pluripotent stem cells (iPS) – as published today in the international journal Stem Cells.

The breakthrough is a significant step in improving the quality of iPS cells and identifying unwanted cells that can form tumours. The test also determines how stable iPS cells are when grown in the lab. Dr Andrew Laslett and his team have spent the last five years working on the project. The research has focused on comparing different types of iPS cells with . iPS cells are now the most commonly used pluripotent stem cell type for research.

"The test we have developed allows us to easily identify unsafe iPS cells. Ensuring the safety of these cell lines is paramount and we hope this test will become a routine screen as part of developing safe and effective iPS-based cell therapies," says Dr Laslett.

Using their test method, Dr Laslett's team has shown that certain ways of making iPS cells carry more risks. When the standard technique is used, which relies on viruses to permanently change the DNA of a cell, unwanted tumours are more likely to form. In comparison, cells made using methods which do not alter cell DNA, do not form tumours.

Dr Laslett hopes the study and the new will help to raise the awareness and importance of stem cell safety and lead to improvements in quality control globally.

"It is widely accepted that iPS cells made using viruses should not be used for human treatment, but they can also be used in research to understand diseases and identify . Having the assurance of safe and stable cells in all situations should be a priority," says Dr Laslett.

The test uses to identify proteins found on the surface of the cells. Based on the presence or absence of specific proteins the cells are then separated and monitored. Unsafe stem cell lines are easily identified because they form recognisable clusters of cells and the safe ones don't. This test could also be applied to assess the safety of the recently announced somatic cell nuclear transfer human .

Professor Martin Pera, Program Leader of Stem Cells Australia, said: "Although cell transplantation therapies based on iPS cells are being fast-tracked for testing in humans, there is still much debate in the scientific community over the potential hazards of this new technology."

"This important study provides a simple and powerful technique for assessing how safe stem cell lines are for use in patients," he adds.

Explore further: New studies bring scientists closer to combating dangerous unstable proteins

More information: The paper, titled 'Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency' is available on the Stem Cells website.

add to favorites email to friend print save as pdf

Related Stories

Mapping a route to stem cell therapies

May 20, 2013

Monash University researchers are shedding light on the complex processes that underpin the creation and differentiation of stem cells, bringing closer the promise of 'miracle' therapies.

Novel probe for live human iPS cell imaging

May 16, 2013

Researchers from the National Institute of Advanced Industrial Science and Technology (AIST) have developed a highly sensitive lectin probe, rBC2LCN, for human induced pluripotent stem cells (iPS cells). ...

Recommended for you

YEATS protein potential therapeutic target for cancer

17 hours ago

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

19 hours ago

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0